{"filing":{"accession_number":"0001493152-26-038637","cik":"0001468929","ticker":"NXGLW","company_name":"NEXGEL, INC.","form":"8-K","filing_date":"2026-08-17","report_date":"2026-08-17","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226038637/form8-k.htm"},"events":[{"id":28121,"run_id":25704,"accession_number":"0001493152-26-038637","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 8-K discloses NexGel's second quarter 2026 financial results under Item 2.02, with a press release attached as Exhibit 99.1. The filing reports Q2 revenue of $3.69 million and a net loss of $2.87 million for the period ending June 30, 2026, along with operational updates regarding the Celularity acquisition integration and strategic initiatives. This is a standard quarterly earnings release material to investors assessing the company's financial performance.","company_name":"NEXGEL, INC.","ticker":"NXGLW","filing_date":"2026-08-17","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":29933,"accession_number":"0001493152-26-038637","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses NexGel's second quarter 2026 financial results under Item 2.02, with a press release attached as Exhibit 99.1. The filing reports Q2 revenue of $3.69 million and a net loss of $2.87 million for the period ending June 30, 2026, along with operational updates regarding the Celularity acquisition integration and strategic initiatives. This is a standard quarterly earnings release material to investors assessing the company's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T12:16:38.323013+00:00","company_name":"NEXGEL, INC.","ticker":"NXGLW","filing_date":"2026-08-17"}]}